Better get to work bitches…

[Anonymous]

hahahahaha!!!

 

[Anonymous]

Yup. Steve Vickers and the boys from Onyx are about to hand you your lunch. Can't imagine a patient or physician wanting to deal with neurotoxicity city with carfilzomib on the market.

 

[Anonymous]

Oh, you're right, docs would rather gamble with cardiac arrest and pneumonia! Read the press, PN no longer a problem with SC.
Great news for patients with 3+ lines of failed therapy but Velcade will do just fine!

 

[Anonymous]

Keep drinking that kool aid. Steve-o knows where all the velcade skeletons are buried. Next up...they start hiring your best reps.

 

[Anonymous]

Oh, you're right, docs would rather gamble with cardiac arrest and pneumonia! Read the press, PN no longer a problem with SC.
Great news for patients with 3+ lines of failed therapy but Velcade will do just fine!

Cardio and pneumonia was almost identical to Velcade phase 2b. Do your homework next time.

 

[Anonymous]

Keep drinking that kool aid. Steve-o knows where all the velcade skeletons are buried. Next up...they start hiring your best reps.

Onyx has already extended offers to Millenium reps. They are just waiting for the July 16 start date. They were made verbal offers months ago.

 

[Anonymous]

The smart reps will be attending training in S SF sometime in August. This POS is going to get gutted.

 

[Anonymous]

Cardio and pneumonia was almost identical to Velcade phase 2b. Do your homework next time.

Let's wait to see how the label reads...Maybe even a black box?

 

[Anonymous]

Let's wait to see how the label reads...Maybe even a black box?

Yeah because oncologists get nervous about boxed warnings...go back to primary care loser.

 

[Anonymous]

+1. Hematologists care about efficacy. That is why Velcade's growth days are over. Good times in South SF.